Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-77,757
Closed -$935K 1215
2025
Q1
$935K Buy
77,757
+53,370
+219% +$698K 0.02% 778
2024
Q4
$269K Sell
24,387
-183
-0.7% -$2.57K 0.01% 1014
2024
Q3
$398K Buy
24,570
+5,202
+27% +$72.7K 0.01% 944
2024
Q2
$210K Buy
+19,368
New +$238K 0.01% 1263
2021
Q1
Sell
-37,170
Closed -$125K 463
2020
Q4
$125K Sell
37,170
-15,790
-30% -$59.3K 0.04% 370
2020
Q3
$207K Buy
52,960
+39,830
+303% +$145K 0.07% 309
2020
Q2
$70K Buy
+13,130
New +$60.5K 0.02% 386

Other funds holding EOLS

Algert Global's EOLS Position: Q2 2025 in Review

Algert Global sold out of Evolus (EOLS) in Q2 2025, closing a stake of 77,757 shares — an estimated $935K sold.

Algert Global first reported a position in EOLS in Q2 2020 and held it in 7 quarters. The position peaked at $935K in Q1 2025. 172 funds tracked by Wall St. Rank hold EOLS as of Q2 2025.

  • Algert Global reported no remaining Evolus position as of Q2 2025 after selling out during the quarter.
  • Algert Global sold 77,757 Evolus shares in Q2 2025, an estimated $935K.
  • Algert Global first reported a position in Evolus in Q2 2020 and held it in 7 quarters.
  • Algert Global's Evolus position peaked at $935K in Q1 2025.
  • 172 funds tracked by Wall St. Rank held Evolus as of Q2 2025.

Based on Algert Global's 13F filing for Q2 2025, filed 14 Aug 2025.